[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
Global Genetic Mutation Analysis Market
Pharmaceuticals

How Will The Genetic Mutation Analysis Market Expand At A CAGR Of 11.6% Through 2029?

Uncover key drivers, emerging technologies, and competitive movements shaping the genetic mutation analysis market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Genetic Mutation Analysis Market Today And What Is Its Future Size?

The genetic mutation analysis market has experienced substantial growth in recent years. It is projected to expand from $5.94 billion in 2024 to $6.65 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.9%. This past growth can be attributed to the increasing prevalence of genetic disorders and inherited diseases, growing awareness of personalized medicine’s benefits, rising technological advancements in sequencing techniques, increasing adoption of liquid biopsy methods, and growing integration of AI and big data analytics.

The genetic mutation analysis market is projected to experience substantial expansion over the upcoming years. This market is predicted to reach $10.30 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.5%. During this projected period, factors contributing to its growth include an increase in governmental support and financial investment in genomics research, a heightened need for early detection of diseases and proactive screening, broader availability of direct-to-consumer (DTC) genetic tests, an expanding requirement in monitoring oncology and infectious diseases, and an elevated emphasis on genetic uses in reproduction and prenatal care. Key trends anticipated during the forecast period encompass progress in sequencing methods, the incorporation of artificial intelligence and bioinformatics instruments, technological innovations for identifying rare mutations, developments in lab-on-a-chip and microfluidics, and the adoption of accelerated computing solutions.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27297&type=smp

What External And Internal Drivers Are Influencing The Genetic Mutation Analysis Market?

The genetic mutation analysis market is projected to grow significantly due to the increasing prevalence of genetic disorders. These disorders are conditions resulting from abnormalities or mutations in an individual’s DNA, which can be inherited or occur spontaneously. The rising incidence of genetic disorders is partly attributed to advanced parental age, which elevates the risk of genetic mutations during reproduction, subsequently increasing the likelihood of these conditions in offspring. Genetic mutation analysis identifies changes in genes that can indicate or lead to genetic disorders, thereby facilitating early diagnosis, precise treatment, and well-informed reproductive or lifestyle decisions. For instance, in October 2024, the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, reported that the number of registered cystic fibrosis patients rose from 11,148 in 2022 to 11,318 in 2023, reflecting a 1.5% year-over-year increase in patient registrations. Consequently, the escalating prevalence of genetic disorders is a primary driver for the expansion of the genetic mutation analysis market.

How Is The Genetic Mutation Analysis Market Categorized Across Applications And Types?

The genetic mutation analysis market covered in this report is segmented

1) By Component: Hardware, Software, Services

2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics

4) By End User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories

Subsegment:

1) By Hardware: Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems

2) By Software: Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools

3) By Services: Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services

How Are Market Trends Influencing Competition In The Genetic Mutation Analysis Market?

Leading companies within the genetic mutation analysis market are concentrating on developing innovative solutions, such as tissue-based next-generation sequencing (NGS) tests, to enhance the accuracy of identifying actionable genetic alterations and to guide personalized treatment strategies. These tissue-based next-generation sequencing (NGS) tests serve as advanced diagnostic tools that analyze DNA or RNA from a tissue sample to detect genetic mutations, alterations, or biomarkers associated with diseases like cancer. For instance, in June 2024, Guardant Health Inc., a US-based oncology company, introduced the Guardant360 TissueNext test, which expands the number of genes it identifies in a tumor tissue sample to 498. These genes, or cancer biomarkers, empower oncologists to determine the most effective targeted therapies or treatment strategies for patients battling advanced cancer. In addition to expanding the gene panel, Guardant has also optimized the test’s operational workflow for a faster turnaround time. The new Guardant360 TissueNext test will be covered for Medicare fee-for-service patients with advanced solid tumor cancers as a standalone service, based on coverage communicated by Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostics Services program (MolDX), under the existing local coverage determination.

Who Are The Global Leaders Steering The Genetic Mutation Analysis Market Forward?

Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, and BGI Genomics Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/genetic-mutation-analysis-global-market-report

What Are The Emerging Regional Trends Driving The Genetic Mutation Analysis Market?

North America was the largest region in the genetic mutation analysis market in 2024. The regions covered in the genetic mutation analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27297&type=smp

Browse Through More Reports Similar to the Global Genetic Mutation Analysis Market 2025, By The Business Research Company

Mining Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mining-equipment-global-market-report

Autonomous Mining Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/autonomous-mining-equipment-global-market-report

Mining Machinery And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mining-machinery-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong. [KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.